TA
IDXX icon

TKG Advisors’s Idexx Laboratories IDXX Stock Holding History

TKG Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-509
Closed -$248K – 102
2024
Q2 		$248K Sell
509
-101
-17% -$50.7K 0.13% 86
2024
Q1 		$329K Sell
610
-12
-2% -$6.56K 0.18% 77
2023
Q4 		$345K Sell
622
-544
-47% -$255K 0.21% 69
2023
Q3 		$510K Buy
1,166
+31
+3% +$15.5K 0.34% 62
2023
Q2 		$570K Buy
+1,135
New +$544K 0.37% 56

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TKG Advisors's IDXX Position: Q3 2024 in Review

TKG Advisors sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 509 shares — an estimated $248K sold.

TKG Advisors first reported a position in IDXX in Q2 2023 and held it in 5 quarters. The position peaked at $570K in Q2 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • TKG Advisors reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • TKG Advisors sold 509 Idexx Laboratories shares in Q3 2024, an estimated $248K.
  • TKG Advisors first reported a position in Idexx Laboratories in Q2 2023 and held it in 5 quarters.
  • TKG Advisors's Idexx Laboratories position peaked at $570K in Q2 2023.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on TKG Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.